Cargando…
106. Increased Length of Gender-Affirming Hormone Therapy is Associated with Greater Facial Fat Pad Volume in Transfeminine Patients
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194729/ http://dx.doi.org/10.1097/01.GOX.0000938012.64707.a4 |
_version_ | 1785044075764776960 |
---|---|
author | Moghadam, Shahrzad LaGuardia, Jonnby S. Huang, Kelly X. Bedar, Meiwand Chin, Madeline G. Lee, Justine C. |
author_facet | Moghadam, Shahrzad LaGuardia, Jonnby S. Huang, Kelly X. Bedar, Meiwand Chin, Madeline G. Lee, Justine C. |
author_sort | Moghadam, Shahrzad |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10194729 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-101947292023-05-19 106. Increased Length of Gender-Affirming Hormone Therapy is Associated with Greater Facial Fat Pad Volume in Transfeminine Patients Moghadam, Shahrzad LaGuardia, Jonnby S. Huang, Kelly X. Bedar, Meiwand Chin, Madeline G. Lee, Justine C. Plast Reconstr Surg Glob Open PSRC 2023 Meeting Abstract Supplement Lippincott Williams & Wilkins 2023-05-19 /pmc/articles/PMC10194729/ http://dx.doi.org/10.1097/01.GOX.0000938012.64707.a4 Text en Copyright © 2023 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | PSRC 2023 Meeting Abstract Supplement Moghadam, Shahrzad LaGuardia, Jonnby S. Huang, Kelly X. Bedar, Meiwand Chin, Madeline G. Lee, Justine C. 106. Increased Length of Gender-Affirming Hormone Therapy is Associated with Greater Facial Fat Pad Volume in Transfeminine Patients |
title | 106. Increased Length of Gender-Affirming Hormone Therapy is Associated with Greater Facial Fat Pad Volume in Transfeminine Patients |
title_full | 106. Increased Length of Gender-Affirming Hormone Therapy is Associated with Greater Facial Fat Pad Volume in Transfeminine Patients |
title_fullStr | 106. Increased Length of Gender-Affirming Hormone Therapy is Associated with Greater Facial Fat Pad Volume in Transfeminine Patients |
title_full_unstemmed | 106. Increased Length of Gender-Affirming Hormone Therapy is Associated with Greater Facial Fat Pad Volume in Transfeminine Patients |
title_short | 106. Increased Length of Gender-Affirming Hormone Therapy is Associated with Greater Facial Fat Pad Volume in Transfeminine Patients |
title_sort | 106. increased length of gender-affirming hormone therapy is associated with greater facial fat pad volume in transfeminine patients |
topic | PSRC 2023 Meeting Abstract Supplement |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194729/ http://dx.doi.org/10.1097/01.GOX.0000938012.64707.a4 |
work_keys_str_mv | AT moghadamshahrzad 106increasedlengthofgenderaffirminghormonetherapyisassociatedwithgreaterfacialfatpadvolumeintransfemininepatients AT laguardiajonnbys 106increasedlengthofgenderaffirminghormonetherapyisassociatedwithgreaterfacialfatpadvolumeintransfemininepatients AT huangkellyx 106increasedlengthofgenderaffirminghormonetherapyisassociatedwithgreaterfacialfatpadvolumeintransfemininepatients AT bedarmeiwand 106increasedlengthofgenderaffirminghormonetherapyisassociatedwithgreaterfacialfatpadvolumeintransfemininepatients AT chinmadelineg 106increasedlengthofgenderaffirminghormonetherapyisassociatedwithgreaterfacialfatpadvolumeintransfemininepatients AT leejustinec 106increasedlengthofgenderaffirminghormonetherapyisassociatedwithgreaterfacialfatpadvolumeintransfemininepatients |